Elm Street Ventures
Overview
Elm Street Ventures is a seed and early stage venture fund based in New Haven, Connecticut. Since 2006, the firm has focused on backing Yale faculty engaged in cutting-edge research to address some of the world's largest problems. With Yale as its largest investor, Elm Street Ventures supports teams developing therapeutics, advanced tools, and materials for industry, as well as interventions for climate change. The firm's investment thesis is that great people and great science lead to great impact. They are primarily interested in companies with a Yale connection, typically technology developed at and licensed from Yale. They also invest in companies located in the greater New Haven area, and, in exceptional cases, non-Yale/non-New Haven companies in which they have strong, personal connections to the founders or investors or where they can add substantial value.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| ARVION | Sep 2013 | Series A | Co-investor |
| Saphlux | Apr 2017 | Series A | Co-investor |
| Cybrexa Therapeutics | Mar 2021 | Series B | Co-investor |
| ARIX Technologies | May 2018 | Seed | Co-investor |
| Osmol Therapeutics | Dec 2016 | Series A | Lead |
For institutional investors. Book with your work email.
Key People
Robert Bettigole
Founder And Managing Partner
Christopher McLeod
Managing Partner
Rebecca Velez Frey
Venture Partner
Richard Stahl
Venture Partner
Jonas Clark
Partner
Alaaddin Ibrahimy
Venture Capital Intern
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Elm Street Ventures based?
Elm Street Ventures is headquartered in New Haven, Connecticut, United States.
When was Elm Street Ventures founded?
Elm Street Ventures was founded in 2006.
How many portfolio companies does Elm Street Ventures have?
Elm Street Ventures has 20 portfolio companies in Caplight's dataset.
What are some companies in Elm Street Ventures's portfolio?
Portfolio companies visible on Caplight include ARVION, Saphlux, Cybrexa Therapeutics, ARIX Technologies, Osmol Therapeutics.
What was Elm Street Ventures's most recent investment shown here?
Elm Street Ventures's most recent investment in this portfolio sample was in Cybrexa Therapeutics in 2021.
What sectors does Elm Street Ventures focus on?
Elm Street Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Enterprise Software, Healthcare & Life Sciences, Enterprise Software, Cybersecurity, Frontier & Industrial Tech, Energy & Sustainability, Frontier & Industrial Tech, Enterprise Software, Enterprise Software, Media, Entertainment & Gaming, Consumer & Commerce, Frontier & Industrial Tech, Real Estate & PropTech, Energy & Sustainability.
What company stages does Elm Street Ventures focus on?
Elm Street Ventures typically invests at the Early stage.
What is Elm Street Ventures's AUM?
Elm Street Ventures's assets under management are estimated between $50.0M and $100.0M.